According to research reviewed by Gram, a radiofrequency device plus a lower-calorie diet appeared to reduce belly fat more than the device alone in a small 2026 pilot study of 20 middle-aged adults. Visceral fat fell 15.0% versus 9.1%, but this gap was not statistically significant, so larger studies are needed.
A small 2026 study looked at whether a radiofrequency device could help reduce belly fat, alone or together with a lower-calorie diet. According to research reviewed by Gram, 20 middle-aged adults received 12 treatment sessions over six weeks. Both groups lost some abdominal fat. The group that also followed a lower-calorie diet appeared to lose more: about 15.0% of their visceral fat, the fat packed around internal organs, compared with about 9.1% in the device-only group. However, this difference was not statistically significant, meaning it could have happened by chance in such a small group. The diet group also lost more weight and body mass index. Researchers say the results are promising but preliminary, and larger studies are needed before anyone can rely on this treatment.
Key Statistics
A 2026 randomized pilot study of 20 middle-aged adults found that visceral fat, the fat surrounding internal organs, dropped about 15.0% in people who combined a radiofrequency device with a lower-calorie diet, compared with about 9.1% in those who used the device alone.
In the same 2026 pilot study, fat just beneath the skin fell about 18.6% in the combined diet group, while the device-only group saw a reduction of about 9.2%, though the between-group difference was not statistically significant.
The Quick Take
- What they studied: Researchers wanted to know whether a high-power radiofrequency device, which uses heat energy to target fat, could reduce belly fat on its own or work better when paired with a lower-calorie diet.
- Who participated: Twenty middle-aged adults were split into two small groups. One group had an average age of about 58 and included 7 men and 3 women. The other group had an average age of about 54 and included 5 men and 5 women.
- Key finding: Both groups lost belly fat. The group that combined the device with a lower-calorie diet lost about 15.0% of visceral fat and 18.6% of subcutaneous fat, while the device-only group lost about 9.1% and 9.2%. These differences were too small to be considered statistically reliable in this study.
- What it means for you: The results hint that pairing this device with a healthy, lower-calorie eating plan may help more than the device alone. Because the study was small and the differences were not statistically significant, this should be viewed as an early signal, not proof. Talk with a doctor before considering any fat-reduction treatment.
The Research Details
This was a preliminary randomized pilot study. Randomized means participants were placed into groups by chance, which helps reduce bias. Pilot means the study was a small first test designed to see whether a larger study is worth doing.
The 20 participants were divided into two groups. One group received 12 sessions of treatment with a four-channel high-power radiofrequency device over six weeks, along with a lower-calorie eating plan. The other group received the same device sessions without the diet plan. Researchers measured body weight, body mass index (a measure of weight relative to height), blood markers, and fat volume in the belly using imaging. Visceral fat was checked again three months after treatment.
Because the study was small, its results are best seen as a starting point. Researchers used the pilot design to test methods and gather early information rather than to prove that the treatment works.
Randomizing participants helps make fair comparisons between the two groups, so differences are less likely to come from who happened to join each group. Measuring fat with imaging, rather than only using a tape measure or scale, gives a more precise picture of fat inside and under the skin.
The design also allowed researchers to track results after treatment ended. The three-month follow-up showed whether any fat loss lasted beyond the initial six weeks, which is important for judging whether a treatment is worth considering.
The study used random assignment and objective imaging, both strengths. However, the sample of 20 people is very small, and the groups were not identical in age or sex makeup. The study was labeled exploratory, which means its main goal was to generate ideas rather than confirm them. Results from small pilot studies often change when larger studies are run. Readers should treat the findings as preliminary.
What the Results Show
Both groups showed reductions in abdominal fat volume after treatment. This means the device appeared to reduce belly fat even without a diet plan. Researchers saw a clear pattern in the numbers, but the pattern alone did not meet the standard for statistical significance.
The group that combined the device with a lower-calorie diet showed larger average reductions. Visceral fat dropped about 15.0%, and subcutaneous fat, the fat just beneath the skin, dropped about 18.6%. The device-only group saw visceral fat fall about 9.1% and subcutaneous fat fall about 9.2%. Statistical significance is a way of judging whether a difference is likely real rather than due to chance. In this study, the gap between the groups for these two fat types did not reach that threshold.
Weight and body mass index changes did favor the diet group in a clearer way. This is not surprising, since eating fewer calories typically leads to weight loss. Most blood markers did not show clear differences between the groups. Some exploratory differences appeared for triglycerides (a type of blood fat), insulin, and a measure of insulin resistance called HOMA-IR, but these findings were not the study’s main focus and should be interpreted carefully.
At the three-month follow-up, visceral fat was still below starting levels in both groups. This suggests that some of the benefit may last after treatment ends, though the study was too small to know how long results would hold.
The exploratory changes in triglycerides, insulin, and HOMA-IR are interesting because these markers relate to metabolic health, which affects blood sugar and heart risk. Still, with only 20 participants, these patterns could easily be due to chance. They are best viewed as possible leads for future research.
The researchers also noted that both treated groups saw reductions in fat, which supports the idea that the device itself has some effect. This matters because some people may want a treatment option that does not depend entirely on dieting.
Doctors and researchers generally agree that losing visceral fat is linked to better metabolic and heart health, and that combining lifestyle changes such as diet with other approaches often produces the strongest results. This study fits that broader pattern, since the diet group saw larger changes. Research on radiofrequency and similar energy-based fat treatments is still developing, and most studies on these devices are small. This pilot adds to that early body of evidence without settling the question.
The biggest limitation is the small sample size of 20 people, which makes it hard to detect real differences between groups. Many results that look promising in small studies do not hold up in larger ones.
The two groups also differed somewhat in average age and in their mix of men and women, which could influence results. The study was labeled exploratory, so it was not designed to confirm treatment effects. The longer-term follow-up was limited to visceral fat, and it is unclear how long any benefits would last or whether they would be safe over many years. Finally, the study was not large enough to show whether the device affects heart health or long-term disease risk.
The Bottom Line
Based on this early study, combining a high-power radiofrequency treatment with a lower-calorie diet may reduce belly fat more than the treatment alone. Confidence in this finding is low to moderate because the study was small and the difference between groups was not statistically significant. Confidence that the device reduces belly fat at all is also modest, since the study lacked a no-treatment comparison group. Anyone considering this approach should discuss it with a healthcare provider first, and should not treat it as a replacement for proven strategies like regular physical activity and balanced eating.
People who are interested in reducing abdominal fat and who are considering cosmetic or body-contouring treatments may find this research useful. Adults with metabolic concerns, such as high triglycerides or insulin resistance, may also want to know that researchers are exploring new options. People who are pregnant, have implanted medical devices, have a history of certain heart or cancer conditions, or have other health concerns should speak with a doctor before considering any device-based treatment. Those who are looking for a proven, low-cost way to reduce belly fat should focus first on diet and exercise.
In this study, participants completed their treatment sessions over six weeks, and visceral fat was still lower at three months. Realistic expectations are modest: any changes would likely appear gradually over weeks to months, not overnight. Results also vary from person to person. Because the research is preliminary, there is no established timeline for long-term benefits, and anyone hoping to keep fat off should expect to continue healthy habits.
Frequently Asked Questions
Does a radiofrequency device help reduce belly fat?
A 2026 pilot study of 20 middle-aged adults found that a high-power radiofrequency device reduced abdominal fat volume in both treated groups. Because the study was small and lacked a no-treatment control group, researchers say larger studies are needed to confirm how well it works.
Is combining radiofrequency treatment with a diet better than treatment alone?
The combined group lost about 15.0% of visceral fat compared with about 9.1% in the device-only group. However, this difference was not statistically significant in the small 2026 study, so the advantage remains uncertain until larger trials are completed.
How long do the effects of radiofrequency belly fat treatment last?
In a 2026 pilot study, visceral fat remained below starting levels three months after six weeks of treatment in both groups. Researchers have not yet established how long benefits last beyond that point, so long-term effects remain unknown.
What is visceral fat and why does it matter?
Visceral fat is the fat stored deep in the abdomen around organs such as the liver and intestines. Researchers link higher levels to metabolic and heart health risks, which is why scientists study ways to reduce it.
Want to Apply This Research?
- Track waist circumference once a week, measured at the same point (usually just above the belly button) and at the same time of day. Also log your daily calorie intake and weekly body weight. Waist measurements are a simple, practical way to notice changes over time without special equipment.
- If you are following a lower-calorie eating plan, use the app to set a daily calorie target that is realistic for your needs and check in each day. Log meals, prioritize vegetables and lean proteins, and note how you feel. Consistency with diet appears to matter, so set reminders to log meals and review your weekly progress.
- Plan to measure waist circumference, weight, and body mass index monthly over at least six months. Record any treatments or dietary changes in the app so you can see how each affects your numbers. If you have a healthcare provider, consider sharing your logs at check-ups, and ask whether blood markers such as triglycerides or blood sugar should be checked periodically.
This article summarizes a small, preliminary research study and is for general information only. It is not medical advice. Results from 20 participants may not apply to others, and the study has not yet been confirmed by larger trials. Before starting any device-based treatment, changing your diet significantly, or making decisions about your health, consult a qualified healthcare provider, especially if you have heart disease, diabetes, pregnancy, implanted medical devices, or other medical conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.